Cargando…

A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms

Most women experience vasomotor symptoms (VMS) during their menopausal transition. Menopausal hormone therapy (HT) is the most effective treatment for VMS, but some women choose not to use HT or have contraindications to using HT. Non-hormonal treatment options should be offered to these symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Paru S, Smith, Taryn L, Nordhues, Hannah C, Kling, Juliana M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921794/ https://www.ncbi.nlm.nih.gov/pubmed/35300283 http://dx.doi.org/10.2147/IJWH.S282396

Ejemplares similares

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis
por: Rhodes, Joshua R., et al.
Publicado: (2023)

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
por: Pinkerton, JoAnn V., et al.
Publicado: (2015)

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause
por: Portman, David J., et al.
Publicado: (2014)

Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
por: Khan, Saira J, et al.
Publicado: (2023)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review
por: Iliodromiti, S, et al.
Publicado: (2019)

Vasomotor Symptoms: More Than Temporary Menopausal Symptoms
por: Ryu, Ki-Jin, et al.
Publicado: (2020)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action
por: Abdi, Fatemeh, et al.
Publicado: (2016)

A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients
por: Drewe, Juergen, et al.
Publicado: (2015)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
por: Utian, Wulf H
Publicado: (2005)

The effects of paroxetine therapy on depressive symptom and motor function in the treatment of depression with Parkinson’s disease: A meta-analysis
por: Jiang, Li-Lin, et al.
Publicado: (2023)

Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
por: Singhal, Savita Rani, et al.
Publicado: (2016)

Vasomotor and physical menopausal symptoms are associated with sleep quality
por: Kim, Min-Ju, et al.
Publicado: (2018)

Psychosomatic and vasomotor symptom changes during transition to menopause
por: Augoulea, Areti, et al.
Publicado: (2019)

MON-387 Pheochromocytoma Masquerading as Vasomotor Menopausal Symptoms
por: Xhikola, Majlinda, et al.
Publicado: (2019)

The Cause of Vasomotor Symptoms: Resonance Phenomena in the Vascular Bed
por: Uohashi, Keiko
Publicado: (2022)

Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms
por: Yang, Yihui, et al.
Publicado: (2023)

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review
por: Carranza-Lira, Sebastián
Publicado: (2009)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
por: Jaeger, Marianna de B., et al.
Publicado: (2020)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
por: Conklin, Melissa, et al.
Publicado: (2023)

“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
por: Shaukat, Ayesha, et al.
Publicado: (2023)

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019)

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions
por: Pachman, Deirdre R, et al.
Publicado: (2010)

Vasomotor Tumentia
por: Goodall, Alexander
Publicado: (1928)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression
por: Schalet, Benjamin D., et al.
Publicado: (2016)

Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice
por: Kantor, Sandor, et al.
Publicado: (2017)

Comparison of Tolerance of Venlafaxine, Paroxetine and Amitriptyline in Depression Therapy
por: Miskovic, Mirjana
Publicado: (2015)

The Treatment of Vasomotor Rhinitis With Intranasal Corticosteroids
por: Meltzer, Eli O
Publicado: (2009)

The Role of Antihistamines in the Treatment of Vasomotor Rhinitis
por: Lieberman, Phil
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gk3mj67fibt06rmak8cgkl3h2q